Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis

[1]  S. Spiegel,et al.  Murine model of long-term obstructive jaundice. , 2016, The Journal of surgical research.

[2]  J. Sévigny,et al.  Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers. , 2016, Journal of hepatology.

[3]  D. Vergani,et al.  DYSFUNCTIONAL CD39 REGULATORY T CELLS AND ABERRANT CONTROL OF T HELPER TYPE 17 CELLS IN AUTOIMMUNE HEPATITIS Short title: CD39 REGULATORY T CELLS IN AUTOIMMUNE HEPATITIS , 2016 .

[4]  D. Thabut,et al.  Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles , 2015, Hepatology.

[5]  G. Enikolopov,et al.  NTPDase2 and Purinergic Signaling Control Progenitor Cell Proliferation in Neurogenic Niches of the Adult Mouse Brain , 2015, Stem cells.

[6]  D. Schuppan,et al.  Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. , 2014, Gastroenterology.

[7]  R. Sullivan,et al.  Nucleoside Triphosphate Diphosphohydrolase-1 Ectonucleotidase Is Required for Normal Vas Deferens Contraction and Male Fertility through Maintaining P2X1 Receptor Function* , 2014, The Journal of Biological Chemistry.

[8]  K. Iwaisako,et al.  Origin of myofibroblasts in the fibrotic liver in mice , 2014, Proceedings of the National Academy of Sciences.

[9]  P. Insel,et al.  Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis. , 2014, American journal of physiology. Cell physiology.

[10]  D. Vergani,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Dysfunctional CD39 Regulatory T Cells and Aberrant Control of T-Helper Type 17 Cells in Autoimmune Hepatitis , 2014 .

[11]  G. Burnstock,et al.  Purinergic signalling in the liver in health and disease , 2014, Purinergic Signalling.

[12]  V. Kuchroo,et al.  IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 , 2013, Nature Immunology.

[13]  M. Olman,et al.  Adenosine 2A Receptor Antagonist Prevented and Reversed Liver Fibrosis in a Mouse Model of Ethanol-Exacerbated Liver Fibrosis , 2013, PloS one.

[14]  G. Fürst,et al.  CD39 Modulates Hematopoietic Stem Cell Recruitment and Promotes Liver Regeneration in Mice and Humans After Partial Hepatectomy , 2013, Annals of surgery.

[15]  Patrizia,et al.  Purinergic P2Y2 Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice with Acute Liver Injury , 2012 .

[16]  D. Schuppan,et al.  Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice. , 2011, Gastroenterology.

[17]  B. Ryffel,et al.  Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. , 2010, American journal of respiratory and critical care medicine.

[18]  J. Dranoff,et al.  Portal fibroblasts: Underappreciated mediators of biliary fibrosis , 2010, Hepatology.

[19]  D. Candinas,et al.  Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration. , 2008, Gastroenterology.

[20]  J. Dranoff,et al.  IL-6 downregulates transcription of NTPDase2 via specific promoter elements. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[21]  H. Willenbring,et al.  A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice , 2008, Nature Protocols.

[22]  D. Jain,et al.  Prevention of liver fibrosis by the purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS). , 2007, In vivo.

[23]  K. Zatloukal,et al.  A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. , 2007, The American journal of pathology.

[24]  V. Kuchroo,et al.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.

[25]  T. Libermann,et al.  Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes , 2006, Neuroscience.

[26]  T. Finger,et al.  Nucleoside triphosphate diphosphohydrolase‐2 is the ecto‐ATPase of type I cells in taste buds , 2006, The Journal of comparative neurology.

[27]  D. Schuppan,et al.  Halofuginone Induces Matrix Metalloproteinases in Rat Hepatic Stellate Cells via Activation of p38 and NFκB* , 2006, Journal of Biological Chemistry.

[28]  N. Fausto,et al.  Liver regeneration , 2006, Hepatology.

[29]  E. Aquino,et al.  Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor , 2005, Molecular and Cellular Biochemistry.

[30]  J. Dranoff,et al.  Portal Fibroblasts Regulate the Proliferation of Bile Duct Epithelia via Expression of NTPDase2* , 2005, Journal of Biological Chemistry.

[31]  D. Jain,et al.  Ectonucleotidase NTPDase2 Is Selectively Down-Regulated in Biliary Cirrhosis , 2004, Journal of Investigative Medicine.

[32]  J. Dranoff,et al.  Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[33]  J. Dranoff,et al.  The ecto‐nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver , 2002, Hepatology.

[34]  J. Sévigny,et al.  Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. , 2002, Blood.

[35]  Patricia D. Christie,et al.  Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation , 1999, Nature Medicine.

[36]  H. Zimmermann,et al.  Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. , 1999, European journal of biochemistry.